• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[出血综合征与孤立性α2-抗纤溶酶缺乏症。附病例报告]

[Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].

作者信息

Guermazi S, Khelif A, Conrad J, Ennabli S, Dellagi K

机构信息

Laboratoire d'Hématologie, Institut Pasteur de Tunis, Tunis-Belvedere, (Tunisie).

出版信息

Pathol Biol (Paris). 1997 Jun;45(6):483-6.

PMID:9309264
Abstract

An isolated alpha 2 plasmin inhibitor deficiency is reported in a 33 years old male, presenting repeated intramuscular hematomas since 5 years, spontaneously or after minor traumas. None of other family members were suffering from abnormal bleeding. Screening hemostatic examinations were normal except for a moderately shorted euglobulin lysis time (2 hours). Evaluation of fibrinolysis parameters (plasminogen, plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrin and fibrinogen degradation products, alpha 2 plasmin inhibitor) showed normal values except for alpha 2 plasmin inhibitor which is markedly decreased (activity: 14%, antigen: < 5%). Familial hemostasis investigations have not been performed. This isolated alpha 2 plasmin inhibitor deficiency has been confirmed by two repeated control prelevments. Bleedings episodes were treated with antifibrinolytics agents (tranexamic acid). This case report shows the importance of the diagnostic approach in the laboratory to detect such rare hemostatic abnormalities associated with bleeding tendency.

摘要

据报道,一名33岁男性患有孤立性α2纤溶酶抑制剂缺乏症,自5年前起反复出现肌内血肿,可自发出现或在轻微创伤后出现。其他家庭成员均无异常出血情况。除优球蛋白溶解时间适度缩短(2小时)外,筛查性止血检查均正常。对纤溶参数(纤溶酶原、1型纤溶酶原激活物抑制剂、组织纤溶酶原激活物、纤维蛋白和纤维蛋白原降解产物、α2纤溶酶抑制剂)的评估显示,除α2纤溶酶抑制剂明显降低(活性:14%,抗原:<5%)外,其他参数均正常。未进行家族性止血调查。两次重复的对照检测均证实了这种孤立性α2纤溶酶抑制剂缺乏症。出血发作采用抗纤溶药物(氨甲环酸)治疗。本病例报告显示了实验室诊断方法对于检测此类与出血倾向相关的罕见止血异常的重要性。

相似文献

1
[Hemorrhagic syndrome and isolated alpha 2-antiplasmin deficiency. Apropos of a case].[出血综合征与孤立性α2-抗纤溶酶缺乏症。附病例报告]
Pathol Biol (Paris). 1997 Jun;45(6):483-6.
2
alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
J Clin Invest. 1987 Nov;80(5):1391-400. doi: 10.1172/JCI113217.
3
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency.
Thromb Haemost. 1988 Feb 25;59(1):96-100.
4
Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.α2-抗纤溶酶及其缺乏:纤溶失衡
Haemophilia. 2008 Nov;14(6):1250-4. doi: 10.1111/j.1365-2516.2008.01766.x.
5
Fibrinolysis system in patients with bronchial asthma.支气管哮喘患者的纤溶系统
Med Sci Monit. 2000 Jan-Feb;6(1):103-7.
6
Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.4例儿童因先天性纤溶酶原激活物抑制剂-1缺乏所致的出血素质
Haemostasis. 1999;29(5):286-91. doi: 10.1159/000022514.
7
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
8
Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.疑似淀粉样变性中的过度纤溶:血浆中纤溶酶-α2-纤溶酶抑制物复合物和血管性血友病因子片段的证实
Am J Hematol. 1986 Oct;23(2):153-66. doi: 10.1002/ajh.2830230210.
9
Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.三姐妹先天性α2-纤溶酶抑制剂缺乏症
Haemostasis. 1982;11(3):176-84. doi: 10.1159/000214659.
10
Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1.α2-纤溶酶抑制剂或纤溶酶原激活物抑制剂-1先天性缺乏患者口腔内出血的止血处理
Haemophilia. 2004 Sep;10(5):669-74. doi: 10.1111/j.1365-2516.2004.00914.x.